SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-161910
Filing Date
2020-06-05
Accepted
2020-06-05 12:54:03
Documents
6
Period of Report
2020-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d912015d8k.htm 8-K 22334
2 EX-5.1 d912015dex51.htm EX-5.1 8235
3 EX-10.1 d912015dex101.htm EX-10.1 158242
4 EX-99.1 d912015dex991.htm EX-99.1 14024
5 GRAPHIC g912015g0604192206065.jpg GRAPHIC 2836
6 GRAPHIC g912015g0604193255414.jpg GRAPHIC 2471
  Complete submission text file 0001193125-20-161910.txt   211669
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 20945486
SIC: 2836 Biological Products, (No Diagnostic Substances)